(Q37748500)

22 August 2017

1 reference

title

Early detection of myocardial dysfunction and heart failure (English)

1 reference

22 August 2017

0 references

Geoffrey de Couto

1

1 reference

22 August 2017

Maral Ouzounian

series ordinal

2

1 reference

22 August 2017

Peter P Liu

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

11 May 2010

1 reference

Nature Reviews Cardiology

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

6

1 reference

22 August 2017

334-344

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Tackling heart failure in the twenty-first century

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Palliative care in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Outcome of heart failure with preserved ejection fraction in a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Benchmarks for the assessment of novel cardiovascular biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

State of the art: using natriuretic peptide levels in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

B-type natriuretic peptide in cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

B-type natriuretic peptide levels in obese patients with advanced heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Evaluation of high-sensitivity assays for cardiac troponin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-reactive protein comes of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-reactive protein and risk of heart failure. The Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Inflammation and long-term mortality in acute congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-reactive protein in heart failure: prognostic value and the effect of valsartan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Increased plasma levels of adrenomedullin in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Disease-associated functions of IL-33: the new kid in the IL-1 family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Galectins as modulators of tumour progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Galectin-3: a novel mediator of heart failure development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Redefining heart failure: the utility of genomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Multiple biomarkers for the prediction of first major cardiovascular events and death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Soci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Diastolic Stiffness of the Failing Diabetic Heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Tissue Doppler imaging a new prognosticator for cardiovascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Automated analysis of strain rate and strain: feasibility and clinical implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Comprehensive evaluation of left ventricular strain using speckle tracking echocardiography in normal adults: comparison of three-dimensional and two-dimensional approaches.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

PET and SPECT in cardiovascular molecular imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Imaging myocardial metabolism and ischemic memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Diagnostic and prognostic imaging of the cardiac sympathetic nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.51

Positron emission tomography and molecular imaging

31 March 2020

1 reference

12 December 2020

Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication

1 reference

12 December 2020

Diagnostic capability and reproducibility of strain by Doppler and by speckle tracking in patients with acute myocardial infarction.

1 reference

12 December 2020

Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.

1 reference

12 December 2020

Derivation of engraftable skeletal myoblasts from human embryonic stem cells

1 reference

12 December 2020

Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods.

1 reference

12 December 2020

Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2010.51

1 reference

22 August 2017

1 reference